PRICE T ROWE ASSOCIATES INC /MD/ - ODONATE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ODONATE THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$2,194,000
-64.5%
114,265
-75.2%
0.00%
-100.0%
Q3 2020$6,180,000
-85.8%
460,159
-55.3%
0.00%
-80.0%
Q2 2020$43,574,000
+47.3%
1,029,138
-3.9%
0.01%0.0%
Q1 2020$29,576,000
-15.1%
1,071,217
-0.3%
0.01%0.0%
Q4 2019$34,851,000
+25.6%
1,073,981
+0.7%
0.01%
+25.0%
Q3 2019$27,756,000
-27.4%
1,066,320
+2.3%
0.00%
-20.0%
Q2 2019$38,247,000
+367.9%
1,042,446
+182.0%
0.01%
+400.0%
Q1 2019$8,175,000
+57.1%
369,725
+0.0%
0.00%0.0%
Q4 2018$5,204,000
+6.9%
369,625
+47.5%
0.00%0.0%
Q3 2018$4,866,000250,6710.00%
Other shareholders
ODONATE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Boxer Capital, LLC 4,207,086$5,553,0000.28%
Samsara BioCapital, LLC 700,421$925,0000.23%
Hennion & Walsh Asset Management, Inc. 69,264$91,0000.01%
ACADIAN ASSET MANAGEMENT LLC 384,995$506,0000.00%
Tower Research Capital LLC (TRC) 43,752$58,0000.00%
SIMPLEX TRADING, LLC 2,000$2,0000.00%
Newbridge Financial Services Group, Inc. 47$00.00%
BESSEMER GROUP INC 230$00.00%
View complete list of ODONATE THERAPEUTICS INC shareholders